Accessibility Menu
BICO Group logo

BICO Group(OM) BICO

Market CapSEK 1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+5%
5 Year-97%
1 Year-64%
1 Month-11%
SEK 14.48
+1.26%
+0.18Today
BICO Group last closing stock price
MetricPriceDate
Last closeSEK 14.282026-07-28
BICO Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.54%SEK 13.662026-07-21
1 month-11.19%SEK 16.082026-06-26
3 month-31.01%SEK 20.702026-04-29
Year to date-32.19%SEK 21.062025-12-30
1 year-64.03%SEK 39.702025-07-28
3 year-66.16%SEK 42.202023-07-28
5 year-97.49%SEK 570.002021-07-29
Since inception+4.95%SEK 13.632016-11-03

BICO Group Financials at a Glance

Market Cap

SEK 1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.49B

Net Income (TTM)

-SEK 986.20M

EPS (TTM)

-SEK 13.97

P/E Ratio

-1.02

Dividend

SEK 0.00

Beta (Volatility)

1.46 (Average)

Price

SEK 14.48

Volume

254,400

Open

SEK 14.44

Previous Close

SEK 14.30

Daily Range

SEK 14.00 - SEK 14.50

52-Week Range

SEK 12.94 - SEK 40.88

Estimated Earnings Date

Aug 19, 2026

BICO News

3D-bioprinter

How BICO Will Shape the Future of 3D Bioprinting

Motley Fool StaffJan 8, 2022
cash-flow-red

3 Red Flags Slowing BICO Stock's Growth

Motley Fool StaffJan 7, 2022
acquisition

Why Diluting Its Own Stock Helped BICO

Motley Fool StaffJan 7, 2022
bioprinting

How This Swedish MedTech IPO Surged Over 1000%

Motley Fool StaffJan 7, 2022
testing-cream

This Bioconvergence Company Has the Key to End Animal Testing

Motley Fool StaffJan 6, 2022
biotech-research-lab

This Small-Cap Company Is Flipping the Medtech Model on Its Head

Motley Fool StaffJan 6, 2022
research-lab

How This Healthcare Stock Is Pioneering Bio Convergence

Motley Fool StaffJan 6, 2022
biotech

4 X-Factors That Could Send BICO's Stock Soaring

Motley Fool StaffJan 6, 2022

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BICO Group

BICO Group AB (publ) is a global bio-convergence enterprise, specializing in advanced bioprinting and bioautomation technologies. The company operates across North America, Europe, and Asia, providing innovative solutions to the medical, pharmaceutical, and cosmetic industries.

Products and Services
  • 3D bioprinters and hybrid microscopes for laboratory research
  • Precision dispensing and biosensor technologies for industrial clients
  • Specialized services in tissue engineering and diagnostics
Growth Outlook
  • Revenue of 329.9 million SEK in Q1 2026, showing potential for recovery
  • Gross profit margin improved to 54.1% in Q1 2026
  • Strong cash position with 744.3 million SEK in cash and equivalents
Financial Highlights
  • Net income of -131.3 million SEK in Q1 2026, reflecting ongoing investment
  • Operating expenses totaled 269.8 million SEK in Q1 2026
  • Current ratio of 2.35 indicates strong liquidity position
BICO Group AB (publ) has established itself as a leader in the bio-convergence sector, focusing on innovative technologies that cater to a diverse range of industries. The company's Laboratory Solutions division offers cutting-edge tools and consumables essential for research, while the Bioautomation segment provides advanced automation solutions for diagnostics and industrial applications. Recent financial performance indicates a revenue of 329.9 million SEK in the first quarter of 2026, suggesting a potential rebound from previous quarters. The gross profit margin has notably improved to 54.1%, reflecting enhanced operational efficiency. Despite a net income loss of 131.3 million SEK, the company maintains a robust cash position of 744.3 million SEK, which supports ongoing investments in research and development. The current ratio of 2.35 highlights BICO's strong liquidity, positioning the company well to navigate future challenges and capitalize on growth opportunities. As the demand for bioprinting and bioautomation technologies continues to rise, BICO Group AB (publ) is poised for significant growth in the coming years.
AI Generated • Jul 22, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

602

CEO

Maria Ada Eufemia Forss, MBA

Website

bico.com

Headquarters

Gothenburg, VG 413 46, SE

BICO Financials

Key Financial Metrics (TTM)

Gross Margin

44.96%

Operating Margin

-16.32%

Net Income Margin

-66.09%

Return on Equity

-51.81%

Return on Capital

-7.75%

Return on Assets

-33.20%

Earnings Yield

-98.04%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

SEK 1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

70.57M

Volume

254.40K

Avg. Volume

324.98K

Financials (TTM)

Gross Profit

SEK 671.00M

Operating Income

-SEK 243.50M

EBITDA

-SEK 1.07B

Operating Cash Flow

SEK 39.10M

Capital Expenditure

-SEK 14.90M

Free Cash Flow

SEK 24.20M

Cash & ST Invst.

SEK 744.30M

Total Debt

SEK 690.60M

BICO Group Performance Analysis

BICO Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 2,120,800,00068.7%
20232023-12-31SEK 2,010,400,000-5.2%
20242024-12-31SEK 1,727,200,000-14.1%
20252025-12-31SEK 1,497,200,000-13.3%
BICO Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-16.6%
Q32025-09-3019.3%
Q42025-12-3116.6%
Q12026-03-31-26.9%
BICO Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -12.27230.9%
20232023-12-31SEK -16.6235.4%
20242024-12-31SEK -0.08-99.5%
20252025-12-31SEK -15.4319706.2%
BICO Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3021.4%
Q32025-09-30-231.8%
Q42025-12-3190.3%
Q12026-03-31-121.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 329.90M

-15.1%

Gross Profit

SEK 178.60M

-14.9%

Gross Margin

54.14%

N/A

Market Cap

SEK 1.01BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

SEK 1.81M

N/A

Employees

557

N/A

Net Income

-SEK 131.30M

+43.9%

EBITDA

-SEK 33.20M

-40.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 744.30M

+24.8%

Total Debt

SEK 690.60M

-51.0%

Accounts Receivable

SEK 264.70M

-5.9%

Inventory

SEK 198.00M

-19.9%

Long Term Debt

SEK 626.70M

+142.4%

Short Term Debt

SEK 63.90M

-94.4%

Return on Assets

-33.20%

N/A

Return on Invested Capital

-10.08%

N/A

Free Cash Flow

SEK 42.30M

-39.9%

Operating Cash Flow

SEK 47.30M

-38.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,429.63+0.00%
^DJIDJI
$52,757.94+0.01%
^IXICNASDAQ
$24,885.62-0.00%
BTCBitcoin
$63,630.00-0.02%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.17-0.01%
RIGTransocean
$5.02-0.05%
WULFTeraWulf
$16.85-0.06%
NOKNokia
$8.93-0.03%

Questions About BICO

What is the current price of BICO Group?

BICO Group is trading at SEK 14.48 per share.

What is the 52-week range for BICO Group?

Over the past 52 weeks, BICO Group has traded between SEK 12.94 and SEK 40.88.

How much debt does BICO Group have?

As of the most recent reporting period, BICO Group reported total debt of SEK 690.60M.

How much cash does BICO Group have on hand?

BICO Group reported SEK 744.30M in cash and cash equivalents in its most recent financial results.

What is BICO Group’s dividend yield?

BICO Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services